Departure of Ariad director sparks speculation that Berger's days are numbered
September 22, 2014 at 14:23 PM EDT
The departure of business adviser Robert Whelan from the board of directors at Ariad Pharmaceuticals last week is fueling speculation that CEO and co-founder Harvey Berger may soon be under pressure to step down from the struggling cancer biotech firm...
